The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis
Abstract
OBJECTIVES: Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder. Evidence relating to the treatment of this condition with antidepressants and psychological therapies continues to accumulate. METHODS: We performed an updated systematic review and meta-analysis of randomized controlled trials (RCTs). MEDLINE, EMBASE, and the Cochrane Controlled Trials Register were searched (up to December 2013). Trials recruiting adults with IBS, which compared antidepressants with placebo, or psychological therapies with control therapy or "usual management," were eligible. Dichotomous symptom data were pooled to obtain a relative risk (RR) of remaining symptomatic after therapy, with a 95% confidence interval (CI). RESULTS: The search strategy identified 3,788 citations. Forty-eight RCTs were eligible for inclusion: thirty-one compared psychological therapies with control therapy or "usual management," sixteen compared antidepressants with placebo, and one compared both psychological therapy and antidepressants with placebo. Ten of the trials of psychological therapies, and four of the RCTs of antidepressants, had been published since our previous meta-analysis. The RR of IBS symptom not improving with antidepressants vs. placebo was 0.67 (95% CI=0.58-0.77), with similar treatment effects for both tricyclic antidepressants and selective serotonin reuptake inhibitors. The RR of symptoms not improving with psychological therapies was 0.68 (95% CI=0.61-0.76). Cognitive behavioral therapy, hypnotherapy, multicomponent psychological therapy, and dynamic psychotherapy were all beneficial. CONCLUSIONS: Antidepressants and some psychological therapies are effective treatments for IBS. Despite the considerable number of studies published in the intervening 5 years since we last examined this issue, the overall summary estimates of treatment effect have remained remarkably stable.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“which conflicts with the findings of previous meta-analyses.11,13 This results from the inclusion of a single study, which had the most infrequent sessions and the lowest volume of intervention 18 of the included studies.”
From Systematic review, meta-analysis with subgroup analysis of hypnotherapy for irritable bowel syndrome, effect of intervention characteristics (2021) · cites this paper as [11]
In the citing paper
“Our results were similar to a recently published metaanalysis that used binary outcome data to compare the efficacy of psychotherapy vs antidepressant medications for reducing GI symptoms in IBS.”
From Short-term and long-term efficacy of psychological therapies for irritable bowel syndrome: a systematic review and meta-analysis (2016) · cites this paper as [5]
In the citing paper
“Meta-analyses suggest that psychological therapies are as effective as antidepressants in reducing GI symptoms in IBS immediately after treatment, with a number needed to treat between 2 and 4. [5][6][7]”
From Short-term and long-term efficacy of psychological therapies for irritable bowel syndrome: a systematic review and meta-analysis (2016) · cites this paper as [5]
In the citing paper
“found antidepressants to have efficacy over placebo in the improvement of somatic bowel symptoms (relative risk 0.67; 95% CI 0.58,0.77) with similar effects observed for both selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) 3”
From Antidepressants in Inflammatory Bowel Disease: A Systematic Review (2017) · cites this paper as [3]
In the citing paper
“Antidepressants have also been shown to be effective in treating gastro-intestinal (GI) symptoms associated with some other disorders.”
From Antidepressants in Inflammatory Bowel Disease: A Systematic Review (2017) · cites this paper as [3]
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
Drossman, D. A., Li, Z., Andruzzi, E., Temple, R. D., Talley, N. J., Grant Thompson, W., Whitehead, W. E., Janssens, J., Funch-Jensen, P., Corazziari, E., et al. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303162 · Cited by 2,198
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155
Self-citationWhitehead, W. E., Palsson, O., & Jones, K. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32392 · Cited by 1,116
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramèr, M. R., Nye, B., Carroll, D., Wiffen, P. J., & Moore, A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 926
Antidepressants for neuropathic pain
Saarto, T., & Wiffen, P. J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005454.pub2 · Cited by 806
Research works printed but not linked: 3
- Bergmann, 1991, Die Therapie Des Colon Irritabile Mit Trimipramin (Herphonal) - Eine Kontrollierte Studie., Z Klin Med, 46, 1621
- Boerner, 1988, Wirksamkeit Und Vertraglichkeit Eines Antidepressivuns Beim Colon Irritabile., Therapiewoche, 38, 201
- Vij, 1991, Effect of antidepressant drug (Doxepin) on irritable bowel syndrome patients., Indian J Psychiatry, 33, 243
Cited by
Sorted by citations
Items 301–400 of 405
Reizdarmsyndrom – eine Krankheit
Andresen, V., & Layer, P. (2018) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0043-125224 · Cited by 2
“[9] Ford AC, Quigley EM, Lacy BE et al.”
BackgroundIrritable bowel syndrome – psychiatric issues
Niedziałek, J., Pachla, M., Kordyga, A., Proć, Ł., Soroka, E., & Olajossy, M. (2019) · Current Problems of Psychiatry · doi:10.2478/cpp-2019-0003 · Cited by 2
“Stosowane są benzodiazepiny, TLPD a także selektywne inhibitory receptora serotoninowego [67].”
BackgroundReizdarmsyndrom und funktionelle Dyspepsie
Gottschalk, L., Andresen, V., & Layer, P. (2022) · Der Internist · doi:10.1007/s00108-021-01218-3 · Cited by 2
Serra, J., Aguilar, A., Barba, E., Ríos, C. C. D. L., Pravia, L. G., Martínez, V., & Falcón, B. S. (2024) · Gastroenterology & hepatology · doi:10.1016/j.gastrohep.2024.02.005 · Cited by 2
Levy, R. L., Murphy, T., Heitkemper, M. M., van Tilburg, M. A. L., McMeans, A. R., Chang, J., Boutte, C., Lamparyk, K., Chumpitazi, B. P., & Shulman, R. J. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14093185 · Cited by 2
“In adults and children, abdominal pain only improves in ~40% of patients with CBT, in some cases delaying/supplanting more targeted management [66].”
Gut-directed hypnotherapy for irritable bowel syndrome
Smith, G. D. (2017) · Gastrointestinal Nursing · doi:10.12968/gasn.2017.15.7.20 · Cited by 2
Glickman-Simon, R., & Mukherji, A. (2014) · EXPLORE · doi:10.1016/j.explore.2014.10.010 · Cited by 2
VNS for the Treatment of Inflammatory Disorders of the Gastrointestinal Tract
Bonaz, B. L., Sinniger, V., Sonia Pellissier, A., & Clarençon, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-28612-9_9 · Cited by 3
Moser, G., & Peter, J. (2017) · Zeitschrift für psychosomatische Medizin und Psychotherapie · doi:10.13109/zptm.2017.63.1.5 · Cited by 2
Brown, B. I. (2019) · Gastrointestinal Disorders · doi:10.3390/gidisord1030027 · Cited by 2
“Similarly, psychological therapies including stress reduction and relaxation are beneficial and safe, yet the NNT is 4 [12].”
BackgroundIrritable bowel syndrome with diarrhea: Treatment is a work in progress
Kurin, M., & Cooper, G. S. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.19011 · Cited by 4
Antidepressants for Functional Dyspepsia: New Indications for Old Therapies?
Moayyedi, P., & Anglin, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.12.006 · Cited by 2
Self-citationLövdahl, J., Störsrud, S., & Törnblom, H. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13772 · Cited by 2
Koizumi, K., Hamaguchi, T., Tayama, J., & Fukudo, S. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2706187 · Cited by 2
“If a patient does not respond to these medications, psychosomatic treatments such as cognitivebehavioral therapy, hypnotherapy, and autogenic training have also been shown to be effective [17,18].”
BackgroundXu, X., Huang, Y., Ma, Z., & Liu, Z. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s513906 · Cited by 1
“80,81 Specific brain functions, including sensory processing, emotional regulation, and cognitive processes, arise from dynamic interactions among various brain regions that operate within extensive neural networks.”
Frequency of Celiac Disease in Irritable Bowel Syndrome: Insights From a Tertiary Care Hospital
Warraich, M. U. T., Shafqat, M. N., Ajmal, U., Choudhary, M. A., Shaukat, A. F., Saleem, N., Affan-Ud-Din, M., Khaliq, N., Yaseen, A., & Riaz, H. (2025) · Cureus · doi:10.7759/cureus.89617 · Cited by 2
“Various pharmacological agents are used to provide symptomatic relief and include bulking agents, anti-diarrheal drugs, laxatives, anti-spasmodics, antibiotics, and anti-depressants [4].”
Wei, Q., Rui, M., Wang, Y., Ng, S. C., & You, J. H. S. (2025) · Digestion · doi:10.1159/000549485 · Cited by 1
Ericksonian Hypnotherapy: A Systematic Review and Meta-Analysis of RCTs
Çınaroğlu, M., Yılmazer, E., & Ahlatcıoğlu, E. N. (2026) · Psychiatry International · doi:10.3390/psychiatryint7010016 · Cited by 3
“Hypnotherapy has also shown promise in chronic and psychosomatic conditions: in irritable bowel syndrome (IBS), multiple studies (and clinical guidelines) support gut-focused hypnosis as a beneficial treatment [23], with efficacy comparable to that of cognitive-behavioral therapy (CBT, [24]).”
Chamchoum, E., Ghaleb, J., Chamchoum, N., Khouzami, K. K., Khoury, K. M., Nassif, N., Katrib, N., Karam, K., Hallak, M., & Fiani, E. (2026) · Sage Open Pathology · doi:10.1177/30502098261470867 · Cited by 1
“Since antidepressants have proven to be beneficial in treating irritable bowel syndrome (IBS) symptoms 33 and there is a commonality among FD and IBS, 34 it is plausible that antidepressant therapy can also improve symptoms of dyspepsia.”
Kamkar, A., Golzari, M., Farrokhi, N., Aghaee, S., & Fararouei, M. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Nichtmedikamentöse Therapie des Reizdarmsyndroms
Enck, P., & Mazurak, N. (2017) · Die Gastroenterologie · doi:10.1007/s11377-017-0144-6 · Cited by 1
“Nach einer Metaanalyse aus dem Jahr 2015 [27] liegen für eine Reihe solcher Programme bislang 10 RCT mit insgesamt 886 RDS-Patienten vor.”
BackgroundInfluentialAn acute care approach to functional abdominal pain
Krajicek, E. J., & Hansel, S. L. (2017) · JAAPA · doi:10.1097/01.jaa.0000524711.32966.57 · Cited by 1
Assouline-Dayan, Y. (2018) · Springer eBooks · doi:10.1007/978-3-319-59352-4_38
Screening for psychosocial factors in patients with irritable bowel syndrome
Laird, K. T., & Lackner, J. M. (2017) · NeuroGastroLATAM Reviews · doi:10.24875/ngl.m17000004 · Cited by 1
Is hypnotherapy helpful for irritable bowel syndrome in primary and secondary care?
Palsson, O. S. (2018) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(18)30344-3 · Cited by 1
Peripheral and Central Mechanisms in Irritable Bowel Syndrome : in search of links
Bednarska, O. (2019) · Linköping University medical dissertations · doi:10.3384/diss.diva-156669 · Cited by 1
Twitter debate: controversies in functional gastrointestinal disorders
Maurice, J. B., Widlak, M. M., & Emmanuel, A. V. (2019) · Frontline Gastroenterology · doi:10.1136/flgastro-2019-101246 · Cited by 1
Síndrome de intestino irritable: La importancia de los antiespasmódicos
Fernandez, L. B. B. (2020) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.523 · Cited by 1
Application of the Unified Protocol in Irritable Bowel Syndrome
Zanjani, Z., & Joekar, S. (2023) · doi:10.1093/oso/9780197564295.003.0011 · Cited by 1
Pourkaveh, A., Pirāni, Z., Pourasghar, M., Sadeghı, A., & Poustchi, H. (2023) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs-131811 · Cited by 1
Incorporating FODMAP Dietary Restrictions: Help or Hype?
Wolf, W. A., Kiraly, L. N., & Ireton-Jones, C. S. (2015) · Current Nutrition Reports · doi:10.1007/s13668-015-0131-9 · Cited by 1
Effectiveness of Selective Serotonin Reuptake Inhibitors for Irritable Bowel Syndrome.
Wilkins, T., Agabin, E., & Blake, L. (2015) · PubMed · Cited by 1
Syndrome de l’intestin irritable. Actualités concernant les mécanismes et la prise en charge
Sabaté, J. (2017) · Douleur et Analgésie · doi:10.1007/s11724-017-0533-4 · Cited by 1
Obstáculos en la comunicación entre el cerebro y el intestino
Pletikosić, S., & Tkalčić, M. (2018) · Psihologijske teme · doi:10.31820/pt.27.1.6 · Cited by 2
“IBS is a global disorder whose symptoms are often accompanied by psychological dysfunction such as anxiety and depression, and by a significant impairment of health-related quality of life (Enck et al., 2016; Ford et al., 2014; Lackner et al., 2007; Mykletun et al., 2010; Quigley, 2006; Sibelli et al., 2016; Sood, Gra…”
BackgroundDiarrhea-Predominant Irritable Bowel Syndrome: Medical Management Update
Andrews, C. N., & Bradette, M. (2019) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwz034 · Cited by 1
“Tricyclic antidepressants are also used off-label to treat symptoms of IBS-D, and a recent metaanalysis demonstrated that they may slow gut transit, improve global IBS symptoms and reduce pain (33).”
BackgroundPsychiatric Issues in Older Adults with Gastrointestinal Disorders
Gonzalez-Alonso, R., Gomez, M. F., & O’Dowd, M. A. (2020) · Springer eBooks · doi:10.1007/978-3-319-90761-1_92-1 · Cited by 1
Kingsley, M. J., & Moshiree, B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813037-7.00030-3 · Cited by 1
Pohl, D., Vavricka, S. R., Fox, M. R., Madisch, A., Studerus, D., Wiesel, P. H., Heinrich, H. S., Linas, I., Schoepfer, A. M., Schwizer, A., et al. (2023) · Praxis · doi:10.1024/1661-8157/a003988 · Cited by 1
Efficacy of hypnotherapy in one thousand patients with irritable bowel syndrome
Dube, S., & Ford, A. C. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13184 · Cited by 1
“nolone resistance of up to approximately 26%, a figure higher than that reported in Spain and Southern Italy”.(2) The lack of alternative new antibiotics for H.”
BackgroundInfluentialSelf-citationMujagic, Z., Keszthelyi, D., Thijssen, A. Y., Jonkers, D. M. A. E., & Masclee, A. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13506 · Cited by 1
Leelakusolvong, S., Limsrivilai, J., Charatcharoenwitthaya, P., & Pausawasdi, N. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.294 · Cited by 1
Intending to Treat Patients With Irritable Bowel Syndrome With Cognitive–Behavioral Therapy
Ford, A. C. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.054 · Cited by 1
Self-citationIrritable Bowel Syndrome in Women
Eswaran, S. L., & O’Donohue, L. S. (2019) · Springer eBooks · doi:10.1007/978-3-030-25626-5_13 · Cited by 1
Approach to the Patient with Abdominal Pain
Pasricha, P. J. (2015) · Yamada's Textbook of Gastroenterology · doi:10.1002/9781118512074.ch39 · Cited by 1
Hinse, M., Thronicke, A., Berghöfer, A., & Matthes, H. (2022) · doi:10.31234/osf.io/3a82h · Cited by 1
Vijayvargiya, P., & Prichard, D. O. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780197679753.003.0020 · Cited by 1
Quoi de neuf sur les troubles fonctionnels intestinaux depuis la fin du dernier millénaire ?
Coffin, B. (2015) · Côlon & Rectum · doi:10.1007/s11725-015-0560-4
Letter: irritable bowel syndrome is significantly associated with somatisation – authors’ reply
Patel, P., & Ford, A. C. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13116
Self-citationLinaclotide for irritable bowel syndrome with constipation: a review
Arriaga, M., & Quigley, E. M. M. (2015) · Clinical Investigation · doi:10.4155/cli.15.25
Self-citationMirbagher, L., Gholamrezaei, A., Torkzadeh, F., Danesh, M., Daghaghzadeh, H., Kheiri, S., & Emami, M. H. (2015) · International journal of body, mind and culture · doi:10.22122/ijbmc.v2i1.21
Irritable bowel syndrome: the next-to-last that is being investigated
Domingo, J. J. S. (2016) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2016.05.004
Functional Bowel Disorders for the Colorectal Surgeon
Ayscue, J. M., & Kumar, A. S. (2016) · Springer eBooks · doi:10.1007/978-3-319-25970-3_62
Anale pijn- en disfunctionele klachten en de relatie met het prikkelbaredarmsyndroom
Molenaar, C. B. H., Felt-Bersma, R. J. F., Groot, J., & van Reijn, D. (2016) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-1398-3_9
Dexloxiglumide for the treatment of constipation predominant irritable bowel syndrome
Serra, J., & Caballero, N. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1229306
“published 2009 [16], and revised 2014 [17] by the same authors have shown that both types of antidepressants were effective in providing global symptom relief and reducing pain in IBS.”
BackgroundPharmacological and Clinical Treatment of Irritable Bowel Syndrome
Sałaga, M., & Mosińska, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-49016-8_4
de Wit, N. J. (2017) · Praktische huisartsgeneeskunde · doi:10.1007/978-90-368-0639-8_10
Irritable bowel syndrome: dietetic recommendations and principles of treatment
Makarenko, E. V. (2017) · Vestnik of Vitebsk State Medical University · doi:10.22263/2312-4156.2017.6.23
Guts over fear : internet therapy for abdominal pain in children
Lalouni, M. (2018) · Figshare
Gracie, D. J. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Hypnotherapie bij het prikkelbaredarmsyndroom
Flik, C. E. (2019) · Huisarts en Wetenschap · doi:10.1007/s12445-019-0062-6
The Gut-Brain Connection and Its Significance to Gastroenterologists
Sobin, W. H. (2019) · Springer eBooks · doi:10.1007/978-3-030-18218-2_1
TEKEN, M., Luş, M. G., & Başgül, Ş. S. (2019) · Zeynep Kamil Tıp Bülteni · doi:10.16948/zktipb.500381
Des antidépresseurs pour le syndrome du côlon irritable
Fritsch, P., Kolber, M. R., & Korownyk, C. S. (2020) · PubMed Central
МЕНЕДЖМЕНТ ФУНКЦІОНАЛЬНОЇ ДИСПЕПСІЇ ЗГІДНО З СУЧАСНИМИ НАСТАНОВАМИ І РЕКОМЕНДАЦІЯМИ
Borovyk, I. O. (2020) · Здобутки клінічної і експериментальної медицини · doi:10.11603/1811-2471.2020.v.i2.11299
RNA and inflammatory autoimmune diseases
Gupta, B., Tripathy, A., & Jaiswal, K. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817193-6.00012-1
MEASuRing symptoms in Irritable Bowel Syndrome
Vork, L. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210409lv
Reizdarmsyndrom – eine Krankheit
Andresen, V., & Layer, P. (2018) · Gastroenterologie up2date · doi:10.1055/a-0600-8480
“auf Serotonin-Wiederaufnahmehemmer (SSRI) ausgewichen werden kann [5,9].”
BackgroundIrritable Bowel Syndrome-Strategies for Diagnosis and Management
Kassebaum-Ladewski, A. (2021) · Physician Assistant Clinics · doi:10.1016/j.cpha.2021.05.008
Soifer, L., Tawil, J., Rey, A., Solé, L., & Bernstein, S. (2021) · Acta gastroenteorológica latinoamericana/Acta gastroenterológica latinoamericana · doi:10.52787/kksx5531
Burns, M. P. (2011) · CLOK (University of Central Lancashire)
La 'scrittura di frontiera': autobiografia e altro ne "Il gioco dei regni" di Clara Sereni
Greatti, S. (2009) · Studi Novecenteschi
Ho, E. Y. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734152606.793582238
Gastrointestinal Manifestation and Bipolar Disorder: About a Clinical Case
Stati, S., Tbatou, L., Khallouk, A., Nafiaa, H., & Ouanass, A. (2021) · Scholars Journal of Medical Case Reports · doi:10.36347/sjmcr.2021.v09i11.015
Zhang, G. Q., & North, C. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65725-2
Méndez‐Ferrer, S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732146442.793575333
Psychological Treatments for Gastrointestinal Diseases
Palsson, O. S., Kinsinger, S. W., & Keefer, L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.66020-8
Centrally Mediated Abdominal Pain Syndrome
Tse, S., & Keefer, L. (2019) · Encyclopedia of Gastroenterology · doi:10.1016/b978-0-12-801238-3.66004-x
(2015) · Vandenhoeck & Ruprecht eBooks · doi:10.13109/9783666450327.217
(2016) · Elsevier eBooks · doi:10.1016/b978-3-437-21833-0.16001-2
Song, K. H. (2022) · The Korean Journal of Helicobacter and Upper Gastrointestinal Research · doi:10.7704/kjhugr.2022.0012
Mechanism, Pathophysiology and Herbal Management-A Review on Irritable Bowel Syndrome
Wal, A., Wal, P., Verma, N., Rai, A. K., & Vatsha, P. (2022) · The Natural Products Journal · doi:10.2174/2210315512666220624163105
Repeated Doctor Shopping in Functional Abdominal Pain Patient and Its Impact: A Case Report
Bharti, S., & Sugha, V. (2022) · International Journal of Science and Healthcare Research · doi:10.52403/ijshr.20220759
Ali, M. (2020) · Annals of the Academy of Romanian Scientists Series on Biological Sciences · doi:10.56082/annalsarscibio.2020.2.50
何, 婷. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.12121730
Mindfulness en el síndrome de intestino irritable
Beltrán, C. J., Catherine Iribarne, W., Felipe Valenzuela, M., Navea, C., de Arce, E. P., & Ana María Madrid, S. (2016) · Revista Hospital Clínico Universidad de Chile · doi:10.5354/2735-7996.2016.70852
Funktionelle Magen-Darm-Erkrankungen
Keller, J., & Kandulski, A. (2023) · Die Gastroenterologie · doi:10.1007/s11377-023-00734-y
Kamp, K., Yang, P.-L., Friedman, E., Lopez, A., Iribarren, S., Barney, P., Munson, S. A., Heitkemper, M. M., & Levy, R. L. (2024) · JMIR Formative Research · doi:10.2196/43286 · Cited by 1
“Clinical practice guidelines support the use of behavioral EBPIs for IBS [4,5], yet only a small proportion of patients actually receive such interventions [6].”
BackgroundIntegrative Approaches to Managing Gut Health
Singh, M. (2024) · Current Gastroenterology Reports · doi:10.1007/s11894-024-00927-7 · Cited by 1
“%) of those receiving dynamic psychotherapy in two randomized controlled trials (RCTs) showed improvement in IBS symptoms and the NNT was 3.5 [21].”
InfluentialSerra, J., Aguilar, A., Barba, E., Ríos, C. C. D. L., Pravia, L. G., Martı́nez, V., & Falcón, B. S. (2024) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2024.04.072
Moser, G. (2024) · Springer eBooks · doi:10.1007/978-3-662-68436-8_31
Diagnostik Psychischer Störungen und Psychopharmakologische Therapie
Aigner, M., & Sachs, G. (2024) · Springer eBooks · doi:10.1007/978-3-662-68436-8_27
Avakiants, I. P., Gerasimets, E. A., Петрова, Е. С., & Goryachev, D. V. (2024) · Ведомости Научного центра экспертизы средств медицинского применения · doi:10.30895/1991-2919-2025-15-1-82-91
Moser, G. (2025) · Springer eBooks · doi:10.1007/978-3-662-70440-0_2
Ali, L., Salam, N. A., & Riaz, M. (2025) · Journal of Contemporary Pharmacy · doi:10.56770/jcp2025912
Söderquist, F., Syk, M., Just, D., Kurbalija Novicic, Z., Rasmusson, A. J., Hellström, P. M., Ramklint, M., & Cunningham, J. L. (2020) · Figshare · doi:10.6084/m9.figshare.13226348
White, K., McLaughlin, J. T., Herrick, A. L., Farrer, K., Lal, S., & Hughes, M. (2025) · Clinical gastroenterology · doi:10.1007/978-3-032-07868-1_14
Alhajaji, R., Alfahmi, M. Z., Al-Shareef, E. M., Salim, A. K., Moffareh, A. K., Badirah, S. B., Bafaraj, G. M., & AlDhabei, S. (2026) · Medicine · doi:10.1097/md.0000000000046869
Behavioral Interventions for Health Behaviors in Primary Care
Jackson, K., Montgomery, M., Daniel, R. M., Botello, R., Mixco, G., Mosley, T., Porter, D., Sekula, M. K. K., Swanson, J., Roberman, S., et al. (2026) · Springer eBooks · doi:10.1007/978-3-032-09558-9_9 · Cited by 1
General Principles of Psychopharmacology
Giakas, J. A., & Grossberg, G. T. (2026) · Springer eBooks · doi:10.1007/978-3-032-15772-0_2
Role du fructose dans la physiopathologie du syndrome de l'intestin irritable
Melchior, C. (2018) · theses.fr (ABES) · doi:10.70675/b07649edz908dz4d73za666z0112bc94cdf8
Metadata
- Authors
- Ford, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P.
- Affiliations
- University of Leeds (GB)
- Houston Methodist (US)
- Dartmouth–Hitchcock Medical Center (US)
- Beth Israel Deaconess Medical Center (US)
- Mayo Clinic (US)
- Baylor University Medical Center (US)
- University of Southern California (US)
- VA Greater Los Angeles Healthcare System (US)
- McMaster University (CA)
- Corresponding author
- Ford, Alexander C
- ORCID
- Venue
- American Journal of Gastroenterology
- Published
- 2014-09
- Volume
- 109
- Issue
- 9
- Pages
- 1350-1365
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2171220209
- Cited by
- 405
- References
- 72
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 15 · 2023: 13 · 2022: 27 · 2021: 29 · 2020: 28 · 2019: 51 · 2018: 60 · 2017: 61 · 2016: 46 · 2015: 41 · 2014: 6
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American College of Gastroenterology
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Keywords
- irritable bowel syndrome, antidepressants, psychotherapy, hypnotherapy, cognitive behavioral therapy, tricyclic antidepressants, selective serotonin reuptake inhibitors, psychodynamic psychotherapy, symptom remission, functional gastrointestinal disorders
- MeSH terms
- Antidepressive Agents, Antidepressive Agents, Tricyclic, Humans, Hypnosis, Psychotherapy, Relaxation Therapy, Cognitive Behavioral Therapy, Randomized Controlled Trials as Topic, Selective Serotonin Reuptake Inhibitors, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review